Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Copper Complex. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-step synthesis of N,N-bis-[(R)-(2-methoxy-phenyl) cyanomethyl]-(S)-1-phenylethylamine using copper catalysis for high-purity pharmaceutical intermediates.
Patent CN1852887A details a novel asymmetric copper complex for high-selectivity cyclopropanation, offering cost reduction in pyrethroid manufacturing and reliable supply chain solutions.
Patent CN1384105A details a robust asymmetric copper complex for cyclopropanation, offering significant cost reduction in agrochemical intermediate manufacturing and enhanced supply chain reliability.
Advanced asymmetric copper complex technology for high-purity cyclopropane carboxylates. Enables cost reduction in pharmaceutical intermediates manufacturing and agrochemical production.
Patent CN1968958A details a novel asymmetric copper complex method for high-purity cyclopropane intermediates, offering significant cost reduction in agrochemical manufacturing.
Novel asymmetric synthesis of Beclabuvir intermediate via chiral copper catalysis. High yield, >99% ee, scalable process for API manufacturing.
Patent CN114160206B reveals a novel chiral copper catalyst for optically active indoles. Achieve >91% ee and substantial cost reduction in API manufacturing with scalable processes.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.